Matches in SemOpenAlex for { <https://semopenalex.org/work/W3457550> ?p ?o ?g. }
- W3457550 endingPage "934" @default.
- W3457550 startingPage "911" @default.
- W3457550 abstract "Life's Journey If life is indeed a journey, then poetry must be the map that reveals all its topographic possibilities… while science is the compass that keeps us from getting lost. —R. T. Bartus, Simple Words for Complex Lives, © 1998In the nearly 20 years since the cholinergic hypothesis was initially formulated, significant progress has been achieved. Initial palliative treatments for Alzheimer's disease (AD) have proven beneficial and have gained FDA approval, the use of animal models for studying AD and other neurodegenerative diseases has achieved wider acceptance, and important insight into the potential causes and pathogenic variables associated with various neurodegenerative diseases continues to increase. This paper reviews the current status of the cholinergic hypothesis in the context of continuing efforts to improve upon existing treatments for AD and explores the role that animal models might continue to play. Using the benefit of hindsight, particular emphasis is placed on an analysis of the approaches, strategies, and assumptions regarding animal models that proved useful in developing the initial treatments and those that did not. Additionally, contemporary issues of AD are discussed within the context of the cholinergic hypothesis, with particular attention given to how they may impact the further refinement of animal models, and the development of even more effective treatments. Finally, arguments are presented that, despite the deserved enthusiasm and optimism for identifying means of halting the pathogenesis of AD, a clear need for more effective palliative treatments will continue, long after successful pathogenic treatments are available. This review, therefore, focuses on issues and experiences intended to: (a) facilitate further development and use of animal models for AD and other neurodegenerative diseases, and (b) accelerate the identification of newer, even more effective treatments." @default.
- W3457550 created "2016-06-24" @default.
- W3457550 creator A5002451678 @default.
- W3457550 creator A5059020389 @default.
- W3457550 date "1994-07-01" @default.
- W3457550 modified "2023-09-26" @default.
- W3457550 title "Emerging drugs for alzheimer’s disease: Mechanisms of Action and Prospects for Cognitive Enhancing Medications" @default.
- W3457550 cites W1847168837 @default.
- W3457550 cites W1953027527 @default.
- W3457550 cites W1965420525 @default.
- W3457550 cites W1966182502 @default.
- W3457550 cites W1967580577 @default.
- W3457550 cites W1967674023 @default.
- W3457550 cites W1967893067 @default.
- W3457550 cites W1968294251 @default.
- W3457550 cites W1968634235 @default.
- W3457550 cites W1970757710 @default.
- W3457550 cites W1972300483 @default.
- W3457550 cites W1973278804 @default.
- W3457550 cites W1974607544 @default.
- W3457550 cites W1975693728 @default.
- W3457550 cites W1983258883 @default.
- W3457550 cites W1983916534 @default.
- W3457550 cites W1985261900 @default.
- W3457550 cites W1988485844 @default.
- W3457550 cites W1993700765 @default.
- W3457550 cites W1993935881 @default.
- W3457550 cites W1995391009 @default.
- W3457550 cites W1997130716 @default.
- W3457550 cites W1999385494 @default.
- W3457550 cites W2004413112 @default.
- W3457550 cites W2004713321 @default.
- W3457550 cites W2005202278 @default.
- W3457550 cites W2007627915 @default.
- W3457550 cites W2008171469 @default.
- W3457550 cites W2009850072 @default.
- W3457550 cites W2010120109 @default.
- W3457550 cites W2011230540 @default.
- W3457550 cites W2012444133 @default.
- W3457550 cites W2014772567 @default.
- W3457550 cites W2015123130 @default.
- W3457550 cites W2016057999 @default.
- W3457550 cites W2016599720 @default.
- W3457550 cites W2018593447 @default.
- W3457550 cites W2020961258 @default.
- W3457550 cites W2023055592 @default.
- W3457550 cites W2023773575 @default.
- W3457550 cites W2024578911 @default.
- W3457550 cites W2024960072 @default.
- W3457550 cites W2025543844 @default.
- W3457550 cites W2025947444 @default.
- W3457550 cites W2027366700 @default.
- W3457550 cites W2028843740 @default.
- W3457550 cites W2039940349 @default.
- W3457550 cites W2041976344 @default.
- W3457550 cites W2045669136 @default.
- W3457550 cites W2046454316 @default.
- W3457550 cites W2046623047 @default.
- W3457550 cites W2047158766 @default.
- W3457550 cites W2051834772 @default.
- W3457550 cites W2052293470 @default.
- W3457550 cites W2052496664 @default.
- W3457550 cites W2054113864 @default.
- W3457550 cites W2056046133 @default.
- W3457550 cites W2069304323 @default.
- W3457550 cites W2070502382 @default.
- W3457550 cites W2071136623 @default.
- W3457550 cites W2074759665 @default.
- W3457550 cites W2077531153 @default.
- W3457550 cites W2077579438 @default.
- W3457550 cites W2077887349 @default.
- W3457550 cites W2082950861 @default.
- W3457550 cites W2085695816 @default.
- W3457550 cites W2085743448 @default.
- W3457550 cites W2093374391 @default.
- W3457550 cites W2093613378 @default.
- W3457550 cites W2093641459 @default.
- W3457550 cites W2095828172 @default.
- W3457550 cites W2104227586 @default.
- W3457550 cites W2106625755 @default.
- W3457550 cites W2109167237 @default.
- W3457550 cites W2110765139 @default.
- W3457550 cites W2124452122 @default.
- W3457550 cites W2137195244 @default.
- W3457550 cites W2139211778 @default.
- W3457550 cites W2146398321 @default.
- W3457550 cites W2146729934 @default.
- W3457550 cites W2147478422 @default.
- W3457550 cites W2150487201 @default.
- W3457550 cites W2155087576 @default.
- W3457550 cites W2156220037 @default.
- W3457550 cites W2160456898 @default.
- W3457550 cites W2162998193 @default.
- W3457550 cites W2171405125 @default.
- W3457550 cites W2187766730 @default.
- W3457550 cites W2314133009 @default.
- W3457550 cites W2398740439 @default.
- W3457550 cites W2464068509 @default.